Nexus Medical Partners
15
14M
10
2
0.33
8
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Quincy.
The fund was created by Edwin Snape, John F. Rousseau.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Neurotech, EyeGate Pharmaceuticals, Zipit Wireless Among the most popular fund investment industries, there are Medical, Advanced Materials.
The top activity for fund was in 2008. Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The increased amount of exits for fund were in 2019. This Nexus Medical Partners works on 18 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Nexus Medical Partners, startups are often financed by Windspeed Ventures, VentureSouth, Sunbridge Partners. The meaningful sponsors for the fund in investment in the same round are Upstate Carolina Angel Network, South Carolina Research Authority, Windspeed Ventures. In the next rounds fund is usually obtained by VentureSouth, Medicis Capital, South Carolina Research Authority.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 2
- Exits
- 8
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (9)
- Pharmaceutical (7)
- Medical (6)
- Therapeutics (4)
- Health Care (4) Show 11 more
- Investments by region
-
- United States (14)
- Germany (1)
- Peak activity year
- 2008
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 49M
- Group Appearance index
- 0.87
- Avg. company exit year
- 14
- Avg. multiplicator
- 1.55
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EyeGate Pharmaceuticals | 17 Jan 2007 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 2M | United States, Massachusetts |
| Selah Technologies | 01 May 2008 | Biotechnology, Manufacturing, Advanced Materials, Nanotechnology | Early Stage Venture | 1M | United States, South Carolina |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.